Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in effect between nomifensine and nortriptyline.

W Pöldinger, G Gammel

    International Pharmacopsychiatry
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of unipolar major depression: Algorithms for pharmacotherapy.

    International journal of psychiatry in clinical practice·2014
    Same author

    Depression and cognitive impairment in the elderly: a multicentre study.

    European psychiatry : the journal of the Association of European Psychiatrists·2009
    Same author

    [Treatment of dysthymia].

    Praxis·2001
    Same author

    [St. Johns wort--Hypericum perforatum].

    Praxis·2001
    Same author

    [History of St. Johns wort].

    Praxis·2001
    Same author

    [Problems with sexuality, erotic aspects and love in elderly patients in medical consultation].

    Wiener medizinische Wochenschrift (1946)·1998
    Same journal

    A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Zopiclone: sleep and performance studies in healthy man.

    International pharmacopsychiatry·1982
    Same journal

    Pharmacokinetics and metabolism of zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Evaluation of zopiclone physical dependence liability in normal volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Dose-finding and premedication studies with zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Efficacy and tolerance of zopiclone in insomniac geriatric patients.

    International pharmacopsychiatry·1982
    See all related articles

    This study found nomifensine effective for treating retarded depressions, showing distinct antidepressive and activating effects comparable to nortriptyline. Nomifensine may offer better outcomes, especially for patients who drop out of treatment.

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology

    Background:

    • Retarded depression is a subtype of depression characterized by psychomotor retardation.
    • Antidepressant medications are a cornerstone of treatment for various depressive disorders.

    Purpose of the Study:

    • To compare the efficacy and effects of nomifensine and nortriptyline in outpatients with retarded depressions.
    • To evaluate the antidepressive and activating properties of nomifensine.

    Main Methods:

    • A double-blind, randomized study involving 40 outpatients diagnosed with retarded depression.
    • Patients were assigned to receive either nomifensine or nortriptyline (150 mg/day) for 21 days.
    • Depression symptoms were assessed using a standardized depression scale.

    Main Results:

    Related Experiment Videos

    • Both nomifensine and nortriptyline groups showed significant improvement in psychic symptoms.
    • No statistically significant difference was observed between the two treatment groups overall.
    • Preliminary data from dropouts suggested a potentially better effect profile for nomifensine.

    Conclusions:

    • Nomifensine is a suitable treatment option for patients suffering from retarded depressions.
    • The study highlights nomifensine's antidepressive and activating effects in this patient population.
    • Further investigation into nomifensine's efficacy, particularly in patient subgroups or those with treatment attrition, may be warranted.